Senzime AB

SEZI

SE0002478776

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 08:54:49 20/05/2024 pm IST			5-day change	1st Jan Change
6.68 ^SEK	0.00%		-3.61%	-10.09%

07/05	Transcript : Senzime AB, Q1 2024 Earnings Call, May 07, 2024
07/05	Senzime AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Senzime AB Appoints Eva Walde as New Member of the Board of Directors

March 05, 2021 at 07:58 pm IST

Senzime AB (publ) at extra general meeting of shareholders held on March 5, 2021, elected Eva Walde as new member of the board of directors.

Latest news about Senzime AB

Transcript : Senzime AB, Q1 2024 Earnings Call, May 07, 2024	07/05
Senzime AB Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05	CI
Senzime Signs First Group Purchasing Organization Contract with Major US Hospital System as Sole Source Supplier	26/04	CI
Senzime Announces Major Public Tender Contract by the US Department of Veterans Affairs	24/04	CI
Senzime AB Secures Multiple Top-Rated US Hospital Deals	10/04	CI
Transcript : Senzime AB - Special Call	20/03
Senzime Wins its Largest US Deal to Date from Leading Houston Based University Hospital System	07/03	CI
Transcript : Senzime AB, Q4 2023 Earnings Call, Feb 15, 2024	15/02
Senzime AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	15/02	CI
Senzime Licensee Fukuda Denshi Launches Integrated Tetragraph Module in Japanese Market	07/02	CI
Senzime Bolsters US Operations with Team Expansion, Office Relocation	17/01	MT
Senzime Relocates its US headquarters from Boston to St. Louis, MO	17/01	CI
Senzime AB Secures Initial TetraGraph Order from Major New York Metropolitan Region University Hospital Group	21/12	CI
Senzime AB Secures Multiple University Hospital Orders in Germany	30/11	CI
Senzime AB Announces Board Changes	28/11	CI
Senzime Announces New Clinical Study with the Tetragraph System Published in the British Journal of Anesthesia Open	08/11	CI
Senzime Debuts on OTCQX Market; Stocks Rise	27/23/27	MT
Transcript : Senzime AB, Q3 2023 Earnings Call, Oct 26, 2023	26/23/26
Senzime AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	26/23/26	CI
Senzime Wins Supply Contract for TetraGraph Monitoring System in US	13/23/13	MT
Senzime Secures Contract with University Hospital System	13/23/13	CI
Senzime Launches Tetras Sensitive, the Market's First Sensor for Nemomuscular Monitoring of Patients with Sensitive Skin	09/23/09	CI
Senzime Wins TetraGraph Order in US; Stock Surges	18/23/18	MT
Senzime Secures Additional Major US Hospital Contract	18/23/18	CI
Sweden's Senzime Seeks Listing on OTCQX Trading Platform in US	12/23/12	MT

Senzime publ AB is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.

Sector

Medical Equipment, Supplies & Distribution

Calendar

25/05/2024 - Euroanaesthesia Conference

More about the company

Income Statement Evolution

More financial data

Ratings for Senzime AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SENZIME AB	-10.09%	74.68M
ABBOTT LABORATORIES	-6.01%	181B
MEDTRONIC PLC	+2.65%	114B
BECTON, DICKINSON AND COMPANY	-3.01%	68.29B
DEXCOM, INC.	+5.63%	52.24B
CENCORA, INC.	+7.56%	44.3B
HOYA CORPORATION	+6.67%	42.73B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.73%	32.52B
TERUMO CORPORATION	+20.03%	26.02B
WEST PHARMACEUTICAL SERVICES, INC.	-1.91%	25.91B

Other Medical Equipment, Supplies & Distribution

Senzime AB

Equities

SEZI

SE0002478776

Medical Equipment, Supplies & Distribution

Senzime AB Appoints Eva Walde as New Member of the Board of Directors

Latest news about Senzime AB

Chart Senzime AB

Company Profile

Income Statement Evolution

Ratings for Senzime AB

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution